Who owns the DEX-GATI trademark?

The DEX-GATI trademark is owned by IMPRIMIS PHARMACEUTICALS, INC..

What class is the DEX-GATI trademark registered in?

The DEX-GATI trademark is registered in Class 005 (Pharmaceuticals, medical & veterinary preparations).

What is the serial number for DEX-GATI?

The USPTO serial number for DEX-GATI is 87329838.

What is the registration number for DEX-GATI?

DEX-GATI is registered under USPTO registration number 0.

Sealvo

Home Search: DEX-GATIDEX-GATI #87329838

Back

Updated Oct 10, 2026·11 searches this week

View on USPTO TSDR Find similar marks

DEX

USPTO Trademark Record

ABANDONED

DEX-GATI

SN 87329838·Reg 0·Filed Feb 09, 2017

Owner IMPRIMIS PHARMACEUTICALS, INC.

Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and substances adapted for medical or veterinary purposes, food for babies; dietary supplements for human beings and animals; adhesive plasters, materials for dressings; material for filling teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.

DEX-GATI (Serial No. 87329838), Registration No. 0, is a abandoned US trademark filed on Feb 09, 2017 by IMPRIMIS PHARMACEUTICALS, INC.. This trademark covers Class 005 (Pharmaceuticals, medical & veterinary preparations).

Mark Intelligence

DEX-GATI (Reg. #0) is an abandoned US trademark that was filed in 2017 but has since been abandoned. The mark covers Class 005 (Pharmaceuticals, medical & veterinary preparations). Goods and services include Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and subs....

FILED

Feb 09, 2017

SERIAL

87329838

REG#

Filing Information

StatusABANDONED

Filing DateFeb 09, 2017

Serial Number87329838

Registration No.0

Status DateDec 12, 2018

Mark TypeStandard characters

Attorney Docket20243-301360

Filing Basis & Declarations

Standard Characters ClaimedUse Application CurrentlyTrademark

Full Goods & Services

CLASSES

OFFICE

USPTO

COUNTRY

Class 005Pharmaceuticals, medical & veterinary preparations

US codes: 006, 018, 044, 046, 051, 052

First use anywhere: Feb 01, 2017

First use in commerce: Feb 01, 2017

This description is as filed with the USPTO and defines the scope of trademark protection.

Run a conflict check

Search by serial number, mark name, or logo. See conflicting marks ranked by risk with clear explanations of what contributed.

Run conflict check

Status History

26 events

ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND

Dec 12, 2018

ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND

ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE

Dec 12, 2018

ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE

NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED

May 17, 2018

NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED

NON-FINAL ACTION E-MAILED

May 16, 2018

NON-FINAL ACTION E-MAILED

NOTIFICATION OF NON-FINAL ACTION E-MAILED

May 16, 2018

NOTIFICATION OF NON-FINAL ACTION E-MAILED

NON-FINAL ACTION WRITTEN

May 16, 2018

NON-FINAL ACTION WRITTEN

USE AMENDMENT ACCEPTED

May 16, 2018

USE AMENDMENT ACCEPTED

TEAS/EMAIL CORRESPONDENCE ENTERED

May 12, 2018

TEAS/EMAIL CORRESPONDENCE ENTERED

USE AMENDMENT FILED

May 12, 2018

USE AMENDMENT FILED

AMENDMENT TO USE PROCESSING COMPLETE

May 12, 2018

AMENDMENT TO USE PROCESSING COMPLETE

TEAS REQUEST FOR RECONSIDERATION RECEIVED

May 11, 2018

TEAS REQUEST FOR RECONSIDERATION RECEIVED

CORRESPONDENCE RECEIVED IN LAW OFFICE

May 11, 2018

CORRESPONDENCE RECEIVED IN LAW OFFICE

TEAS AMENDMENT OF USE RECEIVED

May 11, 2018

TEAS AMENDMENT OF USE RECEIVED

NOTIFICATION OF FINAL REFUSAL EMAILED

Dec 05, 2017

NOTIFICATION OF FINAL REFUSAL EMAILED

FINAL REFUSAL E-MAILED

Dec 05, 2017

FINAL REFUSAL E-MAILED

FINAL REFUSAL WRITTEN

Dec 05, 2017

FINAL REFUSAL WRITTEN

CORRESPONDENCE RECEIVED IN LAW OFFICE

Nov 17, 2017

CORRESPONDENCE RECEIVED IN LAW OFFICE

TEAS/EMAIL CORRESPONDENCE ENTERED

Nov 17, 2017

TEAS/EMAIL CORRESPONDENCE ENTERED

ASSIGNED TO LIE

Nov 15, 2017

ASSIGNED TO LIE

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Nov 03, 2017

TEAS RESPONSE TO OFFICE ACTION RECEIVED

PRIORITY ACTION WRITTEN

May 08, 2017

PRIORITY ACTION WRITTEN

PRIORITY ACTION E-MAILED

May 08, 2017

PRIORITY ACTION E-MAILED

NOTIFICATION OF PRIORITY ACTION E-MAILED

May 08, 2017

NOTIFICATION OF PRIORITY ACTION E-MAILED

ASSIGNED TO EXAMINER

May 03, 2017

ASSIGNED TO EXAMINER

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Feb 14, 2017

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

NEW APPLICATION ENTERED

Feb 13, 2017

NEW APPLICATION ENTERED

Other Marks by IMPRIMIS PHARMACEUTICALS, INC.

Additional USPTO filings from the same owner.

IMP

IMPRIMIS

86143561

Imprimis Pharmaceuticals, Inc.

ABANDONED

TRI

TRI-MOXI-VANC

87335606

IMPRIMIS PHARMACEUTICALS, INC.

ABANDONED

LAT

87329849

IMPRIMIS PHARMACEUTICALS, INC.

ABANDONED

SHU

SHUGARCAINE MD

87813592

IMPRIMIS PHARMACEUTICALS, INC.

ABANDONED

Other Marks in Class 005 — Pharmaceuticals, medical & veterinary preparations

Recently filed and registered marks in the same international class.

DEX

79208325

MEDICAL SYMBIOSIS PTY LIMITED

REGISTERED

DEX

DEX-MOXI

86852608

HARROW IP, LLC

REGISTERED

DEX

DEX LABS

98328566

PEARL & ROSE PREMIUM FOODS LLC

REGISTERED

EQU

EQUI-DEX

85511728

Aspen Veterinary Resources, Ltd.

REGISTERED

Other Marks by Antony M. Novom

Additional USPTO filings handled by the same attorney of record.

STA

STAGE GRACE

90121066

REGISTERED

MEL

MELT PHARMACEUTICALS

88163987

ABANDONED

ETO

ETON PHARMACEUTICALS

87443234

ABANDONED

KLA

KLARITY-D

88180080

ABANDONED

DEX-GATI

Run a conflict check

Other Marks by IMPRIMIS PHARMACEUTICALS, INC.

Other Marks in Class 005 — Pharmaceuticals, medical & veterinary preparations

Other Marks by Antony M. Novom

Get pre-filing clearance

Search 14M+ trademarks

Resources

Company